Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma (2017)
- Authors:
- USP affiliated authors: KALIL FILHO, ROBERTO - FM ; MARANHAO, RAUL CAVALCANTE - FCF
- Unidades: FM; FCF
- DOI: 10.1007/s12032-017-1009-z
- Subjects: NANOPARTÍCULAS; CARCINOMA; OVÁRIO
- Language: Inglês
- Imprenta:
- Source:
- Título: Medical Oncology
- ISSN: 1357-0560
- Volume/Número/Paginação/Ano: v. 34, p. 1-7 art. 151, 2017
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
GRAZIANI, Silvia Regina et al. Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma. Medical Oncology, v. 34, p. 1-7 art. 151, 2017Tradução . . Disponível em: https://doi.org/10.1007/s12032-017-1009-z. Acesso em: 31 mar. 2026. -
APA
Graziani, S. R., Vital, C. G., Morikawa, A. T., Eyll, B. M. V., Fernandes Júnior, H. J., Kalil Filho, R., & Maranhão, R. C. (2017). Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma. Medical Oncology, 34, 1-7 art. 151. doi:10.1007/s12032-017-1009-z -
NLM
Graziani SR, Vital CG, Morikawa AT, Eyll BMV, Fernandes Júnior HJ, Kalil Filho R, Maranhão RC. Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma [Internet]. Medical Oncology. 2017 ; 34 1-7 art. 151.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1007/s12032-017-1009-z -
Vancouver
Graziani SR, Vital CG, Morikawa AT, Eyll BMV, Fernandes Júnior HJ, Kalil Filho R, Maranhão RC. Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma [Internet]. Medical Oncology. 2017 ; 34 1-7 art. 151.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1007/s12032-017-1009-z - Removal of chylomicron remnants from the bloodstream is delayed in aged subjects
- Efeito do tratamento do metotrexato associado à nanopartícula de LDE na miocardiopatia diabética induzida por streptozotocina em ratos
- Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model
- Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions
- The expression of lipoprotein receptors is increased in the infarcted area after myocardial infarction induced in rats with cardiac dysfunction
- Alterações no metabolismo e função da Lipoproteína de alta densidade (HDL) em pacientes com doença arterial obstrutiva periférica: implicações para prevenção e tratamento
- Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model
- Plasma lipids and lipid transfer to HDL in long-term bedridden and in sedentary subjects
- Effects of short-term hypothyroidism on the lipid transfer to high-density lipoprotein and other parameters related to lipoprotein metabolism in patients submitted to thyroidectomy for thyroid cancer
- Lipid core nanoparticle associated with docetaxel reduces inflammation and cell proliferation in an atherosclerosis rabbit model
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
